McAnany J Jason, Wanek Justin, Zelkha Ruth, Lim Jennifer I, Chau Felix, Shahidi Mahnaz
*PhD †MS ‡MD Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois.
Optom Vis Sci. 2014 Feb;91(2):194-9. doi: 10.1097/OPX.0000000000000128.
Visual acuity (VA) in normally sighted individuals is highly correlated with equivalent intrinsic blur, a measure of the amount of blur within the visual system that is generated by optical and neural sources. This study assessed the extent to which VA, equivalent intrinsic blur, optical blur, and neural blur are abnormal in subjects with proliferative diabetic retinopathy (PDR) and characterized the relationships among these parameters.
Best-corrected VA of 10 subjects with PDR (ages 25 to 68) and 10 normally sighted individuals (ages 46 to 63) was measured for tumbling E optotypes. The Es were either unblurred or blurred through convolution with Gaussian functions of different widths. Values of equivalent intrinsic blur (σ(int)) and unblurred VA (MAR0) were derived using a standard model. Optical blur (σ(opt)), a measure of blur generated by higher-order aberrations, was quantified using Shack-Hartmann aberrometry. An index of neural blur (η) was defined as 1--σ(opt)/σ(int), which represents the remaining blur once the contributions of σ(opt) to σ(int) have been accounted for.
Log MAR0 and log σ(int) were correlated significantly (r = 0.98, p < 0.05) for the PDR subjects and the values of these parameters ranged from normal to more than a factor of 2 above the upper limit of normal. In comparison, log MAR measured for the most blurred E was elevated by a relatively small amount for all PDR subjects and was not correlated significantly with log σ(int) (r = 0.40, p = 0.25). MAR0, σ(int), and η differed significantly between the PDR subjects and the controls (all p < 0.05) but σ(opt) did not (p = 0.50).
Subjects with PDR and VA loss had higher than normal equivalent intrinsic blur that resulted primarily from neural blur elevations, suggesting that neural blur is an important factor that limits VA in these patients.
正常视力个体的视敏度(VA)与等效内在模糊高度相关,等效内在模糊是一种衡量视觉系统内由光学和神经源产生的模糊量的指标。本研究评估了增殖性糖尿病视网膜病变(PDR)患者的VA、等效内在模糊、光学模糊和神经模糊异常的程度,并描述了这些参数之间的关系。
测量了10例PDR患者(年龄25至68岁)和10例正常视力个体(年龄46至63岁)对翻转E视标的最佳矫正VA。E视标通过与不同宽度的高斯函数卷积进行模糊或不模糊处理。使用标准模型得出等效内在模糊(σ(int))和未模糊VA(MAR0)的值。光学模糊(σ(opt))是由高阶像差产生的模糊的一种度量,使用夏克-哈特曼像差仪进行量化。神经模糊指数(η)定义为1 - σ(opt)/σ(int),它表示在考虑了σ(opt)对σ(int)的贡献后剩余的模糊。
PDR患者的log MAR0和log σ(int)显著相关(r = 0.98,p < 0.05),这些参数的值范围从正常到高于正常上限两倍以上。相比之下,所有PDR患者中,最模糊E视标测量的log MAR升高幅度相对较小,且与log σ(int)无显著相关性(r = 0.40,p = 0.25)。PDR患者与对照组之间的MAR0、σ(int)和η存在显著差异(均p < 0.05),但σ(opt)无差异(p = 0.50)。
患有PDR且视力丧失的患者具有高于正常的等效内在模糊,这主要是由于神经模糊升高所致,表明神经模糊是限制这些患者VA的一个重要因素。